The lack of ER, HER2, and PR expression in triple unfavorable breast tumors presents a big problem in coming up with specific therapies (Katz and Alsharedi 2017). To deal with this, a number of scientific studies have seemed into specific procedures that could be specific in TNBC and not using a wid